Although overall, TREM2/DAP12-dependent cellular activation appears to be beneficial, Jay et al. suggested the possibility that the functional consequence of TREM2/DAP12 signaling depends on the stage of AD, with detrimental effects at the early stage and beneficial effects at the late stage (Jay et al., 2015, 2017). This evidence concerns the gene TREM2 and Alzheimer disease.